Article Sidebar
Views PDF: 1578
RATE OF HPV VACCINATION IN FEMALE STUDENTS AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY
Main Article Content
Abstract
Background: Vaccination against HPV is one of the best ways to prevent cervical cancer, HPV vaccine help to preclude over 90% cancer cause by HPV. Objective: To determine the rate of HPV vaccination to prevent cervical cancer among female students of Can Tho University of Medicine and Pharmacy in 2023. Materials and method: A cross sectional descriptive study controlled over 763 female students by selecting a stratified sample and conducting face-to-face interviews according to a prepared set of questions from January to July 2023. Results: Overall HPV vaccination rate was 35.1%; 1 injection 15.7%; 2 injections 13.1%; 3 injections 71.3%. Cervarix vaccination rate 17.9%; Gardasil 4 accounted for 44.8%; Gardasil 9 accounted for 13.8%; don't remember the vaccine 23.5%. The rate of vaccination among female students in the 6th year accounted for 38.9%; 4th year accounted for 36.7%; the 3rd year accounted for 35.4%, the 2nd year accounted for 20%, the 1st year accounted for 27.1%. HPV vaccination rate 36.7% in general medicine; Next is preventive medicine, accounting for 35.2%. Conclusion: Rate of HPV vaccination was not high in female students, the highest rate in 6th years medicine student.
Article Details
Keywords
HPV vaccination, rate, female student
References
2. Johnson Katanga, Susanne K Kjaer, Rachel Manongi, Chun Sen Wu, Thomas Iftner et al. Performance of care HPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: A cross-sectional study. Plos One. 2019. 1 - 13. Doi.org/10.1371/journal pone 0218559.
3. Dương Mỹ Linh, Trần Ngọc Dung, Phạm Thị Tâm, Bùi Quang Nghĩa. Biến đổi tế bào học cổ tử cung ở phụ nữ thành phố Cần Thơ giai đoạn 2013 – 2020. Tạp chí Y Dược học Cần Thơ. 2021, 35, 86 - 93.
4. Renjie Wanga, Wei Panb, Lei Jina, Weiming Huang, Yuehan Li et al. Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer Letters. 2020. 471, 88–102.
doi.org/10.1016/j.canlet.2019.11.039.
5. Gregory D. Zimet, Beth E. Meyerson, Tapati Dutta, Alice Forster, Brenda Corcoran et al. Political and public responses to human papillomavirus vaccination. Human Papillomavirus, Proving and Using a Viral Cause for Cancer. 2020. 363-377. Doi.org/10.1016/B978-0-12814457-2.00022-2.
6. Lê Văn Hội. Kiến thức, thái độ, thực hành tiêm vắc xin phòng ung thư cổ tử cung của sinh viên nữ khối y học dự phòng Trường Đại Học Y Hà Nội năm 2019. Luận văn thạc sĩ y tế công cộng, Đại Học Y Hà Nội. 2019.
7. Madan Khatiwada, Cissy Kartasasmita, Henny Suzana Mediani, Christine Delprat, Guido Van Hal et al. Knowledge, Attitude and Acceptability of the Human Papilloma Virus Vaccine and Vaccination Among University Students in Indonesia. Frontiers in Public Health. 2021. 9:616456, doi: 10.3389/fpubh.2021.616456.
8. Kah Teik Chew, Nirmala Kampan, Mohamad Nasir Shafiee. Perception and knowledge of human papillomavirus (HPV) vaccine for cervical cancer prevention among fully vaccinated female university students in the era of HPV vaccination: a crosssectional study. BMJ. 2021. 11:e047479. doi:10.1136/bmjopen-2020-047479.
9. Wei- Chen- Tung, Yuting Lin, Hannah W.Chao, Yinghan Chen. HPV vaccination, information sources, and acculturation ampong Chinese college students aged 18 – 26 in the United States. Research in Nursing & Health. 2021. https://doi.org/10.1002/nur.22185.
10. Aimée R. Kreimer, Rolando Herrero, Joshua N. Sampson, Carolina Porras, Douglas R. Lowy et al. Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies. Vaccine. 2018. 36, 4774–4782.
Doi.org/10.1016/j.vaccine.2017.12.078.
11. Phillips, A.; Patel, C.; Pillsbury, A.; Brotherton, J.; Macartney, K. Safety of human papillomavirus vaccines: An updated review. Drug Saf. 2018. 41, 329–346. https://doi.org/10.1007/s40264-017-0625-z.